COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 902
[76] Kuo, H. K., Yen, C. J., Chang, C. H., Kuo, C. K., Chen, J. H., &
Sorond, F. (2005). Relation of C-reactive protein to stroke,
cognitive disorders, and depression in the general population:
systematic review and meta-analysis. The Lancet Neurology, 4(6),
371-380.
[77] Ridker, P. M., Danielson, E., Fonseca, F. A., et al. (2008).
Rosuvastatin to prevent vascular events in men and women with
elevated C-reactive protein. New England Journal of Medicine,
359(21), 2195-2207.
[78] Ridker, P. M., Cannon, C. P., Morrow, D., et al. (2005).
C-reactive protein levels and outcomes after statin therapy. New
England Journal of Medicine, 352(1), 20-28.
[79] American Diabetes Association. (2020). 2. Classification and
diagnosis of diabetes: Standards of Medical Care in
Diabetes-2020. Diabetes Care, 43(Supplement 1).
[80] International Expert Committee. (2009). International Expert
Committee report on the role of the A1C assay in the diagnosis of
diabetes. Diabetes Care, 32(7), 1327-1334.
[81] Nathan, D. M., Balkau, B., Bonora, E., et al. (2009). International
Expert Committee report on the role of the A1C assay in the
diagnosis of diabetes. Diabetes Care, 32(7), 1327-1334.
[82] Gillett, M. J. (2009). International Expert Committee report on
the role of the A1C assay in the diagnosis of diabetes: Diabetes
Care 2009; 32(7): 1327-1334. Clinical Biochemist Reviews, 30(4),
197-200.
[83] Kresser, C. (2019). The optimal A1c level. Chris Kresser.
[84] Bland, J. (2014). The Disease Delusion: Conquering the Causes
of Chronic Illness for a Healthier, Longer, and Happier Life. Harper
Wave.
902
